Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112


Diversity of the CD8+ T cell repertoire elicited against an immunodominant epitope does not depend on the context of infection.

Rudd BD, Venturi V, Smithey MJ, Way SS, Davenport MP, Nikolich-Zugich J.

J Immunol. 2010 Mar 15;184(6):2958-65. doi: 10.4049/jimmunol.0903493. Epub 2010 Feb 17.


Evolution of the antigen-specific CD8+ TCR repertoire across the life span: evidence for clonal homogenization of the old TCR repertoire.

Rudd BD, Venturi V, Davenport MP, Nikolich-Zugich J.

J Immunol. 2011 Feb 15;186(4):2056-64. doi: 10.4049/jimmunol.1003013. Epub 2011 Jan 19.


A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.

Chentoufi AA, Dasgupta G, Christensen ND, Hu J, Choudhury ZS, Azeem A, Jester JV, Nesburn AB, Wechsler SL, BenMohamed L.

J Immunol. 2010 Mar 1;184(5):2561-71. doi: 10.4049/jimmunol.0902322. Epub 2010 Feb 1.


The TCR repertoire of an immunodominant CD8+ T lymphocyte population.

Chen ZW, Li Y, Zeng X, Kuroda MJ, Schmitz JE, Shen Y, Lai X, Shen L, Letvin NL.

J Immunol. 2001 Apr 1;166(7):4525-33.


Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice.

St Leger AJ, Peters B, Sidney J, Sette A, Hendricks RL.

J Immunol. 2011 Apr 1;186(7):3927-33. doi: 10.4049/jimmunol.1003735. Epub 2011 Feb 25.


Recombinant Listeria monocytogenes expressing an immunodominant peptide fails to protect after intravaginal challenge with herpes simplex virus-2.

Muller WJ, Orgun NN, Dong L, Koelle DM, Huang ML, Way SS.

Arch Virol. 2008;153(6):1165-9. doi: 10.1007/s00705-008-0089-7. Epub 2008 Apr 29.


Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.

BenMohamed L, Bertrand G, McNamara CD, Gras-Masse H, Hammer J, Wechsler SL, Nesburn AB.

J Virol. 2003 Sep;77(17):9463-73.


Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection.

Blattman JN, Sourdive DJ, Murali-Krishna K, Ahmed R, Altman JD.

J Immunol. 2000 Dec 1;165(11):6081-90.


Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.

Bettahi I, Nesburn AB, Yoon S, Zhang X, Mohebbi A, Sue V, Vanderberg A, Wechsler SL, BenMohamed L.

Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4643-53.


Acute neonatal infections 'lock-in' a suboptimal CD8+ T cell repertoire with impaired recall responses.

Rudd BD, Venturi V, Smith NL, Nzingha K, Goldberg EL, Li G, Nikolich-Zugich J, Davenport MP.

PLoS Pathog. 2013 Sep;9(9):e1003572. doi: 10.1371/journal.ppat.1003572. Epub 2013 Sep 12.


Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.

Gierynska M, Kumaraguru U, Eo SK, Lee S, Krieg A, Rouse BT.

J Virol. 2002 Jul;76(13):6568-76.


Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses.

Moutaftsi M, Bui HH, Peters B, Sidney J, Salek-Ardakani S, Oseroff C, Pasquetto V, Crotty S, Croft M, Lefkowitz EJ, Grey H, Sette A.

J Immunol. 2007 Jun 1;178(11):6814-20.

Supplemental Content

Support Center